Latest

The Atlanta Legal Examiner provides coverage of personal injury, mass torts, and safety issues making headlines in Atlanta and across the country. Our Latest News section brings together breaking stories and legal insights that matter to individuals, families, and communities.

2015 Best Lawyers® Edition Recognizes M. Brandon Smith

Childers, Schlueter & Smith L.L.C. is proud to announce that firm partner M. Brandon Smith has been listed in the Smith-Best Lawyers 2015 Edition of Best Lawyers®. Best Lawyers® is the oldest and most respected peer-review publication in the legal profession.

By Richard R. Schlueter

/ 18 Aug 2014

Blood Thinner Xarelto Said To Cause Internal Bleeding

Virginia Stuntebeck sued Johnson & Johnson and Bayer AG in Pennsylvania court earlier this year, alleging that she suffered severe internal bleeding stemming from use of the blood-thinning drug Xarelto. In the Xarelto lawsuit, which appears to be the first tort suit filed over the…

By M. Brandon Smith

/ 6 Aug 2014

Blood Thinner Xarelto Said To Cause Internal Bleeding

New Study Results Consistent with Claims Against Stryker Corp. For Failed Hip Implants

Our personal injury lawyers have been investigating claims on behalf of those that have had revision surgeries as a result of metal hip implant complications since the Stryker Rejuvenate modular-neck stem implant recall nearly two years ago. In July 2012, the Stryker Corporation issued a…

By M. Brandon Smith

/ 5 Aug 2014

New Study Results Consistent with Claims Against Stryker Corp. For Failed Hip Implants

Xarelto Among Group of Highly Dangerous Drugs

Anticoagulants such as Xarelto are considered by many to be among the most dangerous drugs because of the high number of serious side effects that are being reported to the U.S. Food and Drug Administration. Xarelto belongs to a class of anticoagulants called direct factor…

By M. Brandon Smith

/ 11 Jul 2014

Xarelto Among Group of Highly Dangerous Drugs

Xarelto Lawsuits Show Rise In Uncontrolled Bleeding Risks

Xarelto, Bayer’s blood thinner formulated to prevent blood clots and lower the risk of stroke, may also cause uncontrolled bleeding that can lead to hospitalization and even death. Xarelto is an anticoagulant developed by Bayer and Johnson & Johnson’s New Jersey-based unit, Janssen Pharmaceuticals.

By M. Brandon Smith

/ 9 Jul 2014

Xarelto Lawsuits Show Rise In Uncontrolled Bleeding Risks

Dangerous Side Effects Linked To Xarelto

Since the drug Xarelto (Rivaroxaban) was approved by the U.S. Food and Drug Administration to treat atrial fibrillation, a condition that causes blood to pool in the storage chamber of the heart where it can clot and travel to the brain, there have been over 2,100…

By M. Brandon Smith

/ 8 Jul 2014

Dangerous Side Effects Linked To Xarelto

GranuFlo Lawsuits-A Game Of Hide And Seek

Injured families and families of lost loved ones have filed lawsuits again Fresenius, the German-based manufacturer of GranuFlo and NaturaLyte, chemicals used in dialysis machines to help clean blood. The suits allege that the chemicals sharply increase the risk of cardiopulmonary arrest and sudden

By M. Brandon Smith

/ 7 Jun 2014

GranuFlo Lawsuits-A Game Of Hide And Seek

NFL Lawsuits and Painkillers-An Alarming Issue

A group of retired NFL players has filed a lawsuit against the league alleging that teams knowingly and illegally supplied players with painkillers and anti-inflammatory drugs to keep them on the field, and held back information regarding the long-term dangers associated with taking the drugs.…

By M. Brandon Smith

/ 5 Jun 2014

NFL Lawsuits and Painkillers-An Alarming Issue

Johnson and Johnson Subsidiary to Pay $5.9M to Settle Risperdal Claim

A Johnson & Johnson subsidiary recently agreed to pay $5.9 million to resolve a suit brought to the company by Tim Fox, Montana’s attorney general. Fox claimed that the drug company promoted the antipsychotic drug Risperdal as safe despite knowing it may incite serious health…

By M. Brandon Smith

/ 16 Apr 2014

Johnson and Johnson Subsidiary to Pay $5.9M to Settle Risperdal Claim

New Risperdal Research Adds Fuel to the Gynecomastia Fire

A study presented at the 2014 Annual Meeting of the American Association for Geriatric Psychiatry concurs with what many young men and boys already know: users of Risperdal may face as much as a 69 percent increased risk of male breast growth, or gynecomastia in…

By M. Brandon Smith

/ 28 Mar 2014

New Risperdal Research Adds Fuel to the Gynecomastia Fire

Anti-Seizure Medication Onfi Linked To Life-Threatening Skin Reactions

Onfi, the brand name version of clobazam, a medication used to treat epileptic seizures, can cause serious skin reactions including Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) according to reports and the FDA. Clobazam is a benzodiazepine medication taken in combination with

By M. Brandon Smith

/ 4 Feb 2014

Anti-Seizure Medication Onfi Linked To Life-Threatening Skin Reactions

Stryker Claims Filed On Defective Hip Implants Continue To Increase

It’s been almost two years since Stryker Rejuvenate hip implants and ABG II hip stems were recalled. In July 2012, the hip implant company took the product off the market after discovering their high potential of causing fretting and corrosion of the joints. But…

By M. Brandon Smith

/ 4 Feb 2014

Stryker Claims Filed On Defective Hip Implants Continue To Increase